Transactions on Cancer (TC)
Transactions on Cancer (TC) is dedicated to promoting and accelerating the dissemination of new research findings. There is a wealth of exciting research activity in this field worldwide. The journal aims to provide academicians and scientists around the globe with a platform to share, promote, and discuss various emerging issues and developments in different areas of cancer science and therapy.
Aims & Scope
Transactions on Cancer (TC) is dedicated to promoting and accelerating the dissemination of new research findings. There is a wealth of exciting research activity in this field worldwide. The journal aims to provide academicians and scientists around the globe with a platform to share, promote, and discuss various emerging issues and developments in different areas of cancer science and therapy.
Aims
- To promote and accelerate the dissemination of new research findings across the field of cancer science and therapy globally.
- To provide academicians and scientists worldwide with a platform to share, promote, and discuss emerging issues and developments in all areas of cancer research and treatment.
- To foster academic exchange, collaboration, and innovation in cancer science, therapy, and translational medicine.
- To advance knowledge and improve patient outcomes through rigorous scholarly publication of cancer research.
Scope
The journal covers a wide range of topics related to cancer science and therapy, including but not limited to:
Cancer Biology and Pathogenesis
- Molecular oncology and genetics, including oncogenes, tumor suppressor genes, and cancer genomics
- Tumor microenvironment and immunology, including immune cell interactions, tumor immunology, and immunotherapy mechanisms
- Cancer cell biology, including cell cycle regulation, apoptosis, metastasis, and angiogenesis
- Cancer epidemiology and risk factors, including environmental, lifestyle, and genetic determinants of cancer
Cancer Therapy and Translational Research
- Targeted therapy and precision oncology, including targeted drug development, personalized medicine, and companion diagnostics
- Immunotherapy and cancer vaccines, including checkpoint inhibitors, adoptive cell therapy, and therapeutic vaccines
- Radiation and surgical oncology, including advanced radiation techniques, minimally invasive surgery, and multimodal treatment approaches
- Translational cancer research, including bench-to-bedside studies, clinical trials, and novel therapeutic strategies